酰氨基硫脲及相关杂环衍生物的研究XXIX: 2-(3'-溴苯胺基)-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑的晶体结构

经1-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-甲酰基]-4-(3'-溴苯基)-3-氨基硫脲在浓硫酸作用下制得2-(3'-溴苯胺基)-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑化合物。该化合物的晶体结构经X射线衍射分析确定, 化合物属三斜晶系, P1空间群, a=1.1784(2), b=1.4455(2),c=1.1353(1)nm; α=100.68(1), β=109.50(1), γ=79.89(1)°; V=1.7779nm^3; 分子式C~1~6H~1~1BrClN~7S, Mr=448.75; Dc=1.673g/cm^3, Z=4,μ=58.16cm^-^1, 最终偏离因子R=0.084, Rw=0.086。分析化合物的键长, 键角数据表明, 该分子具有离域π键结构。     

3-芳基-4-[4′(2,2,6,6-四甲基哌啶-1-氧)]-1,2,4-三唑啉-5-硫酮类的合成

前文指出,各种1,4-二取代的酰氨基硫脲可在碱性物质催化下脱水环化形成1,2,4-三唑啉-5-硫酮类杂环化合物,然而连接2,2,6,6-四甲基哌啶-1-氧自由基的酰氨基硫脲类化合物能否在相同条件下环化脱水形成类似结构的杂环化合物,迄今未见文献报道。各种3,4-二取代的1,2,4-三唑啉-5-硫酮杂环化合物具有广泛的生物活性,如抗菌,杀虫等,而2,2,6,6-四甲基哌啶-1-     

4'-(丹磺酰氨基)苯并冠醚和4'-[α-(丹磺酰氨基)乙基]苯并-15-冠-5的合成

从B12C4, B15C5和B18C6经过硝化、催化氢化和丹磺酰化合成了三种4'-(丹磺酰氨基)苯并冠醚, 从B15C5径乙酰化, Leuckart反应和丹磺酰化合成了另一个4'-[α-(丹磺酰氨)乙基]苯并-15-冠-5这些丹磺酰氨衍生物均为新荧光冠醚.     

Secondary fluorescences of 4'-(1-pyrenyl)acetophenone and p-dimethylaminoacetophenone

4'-(1-Pyrenyl)acetophenone (PYRA) and p-dimethylaminoacetophenone (DMAA) were investigated in nonpolar and polar protic and aprotic solvents over a wide temperature range. Quantum chemical (INDO/S) calculations of the energies of electronic transitions, oscillator strengths and dipole moments were performed for planar and twisted conformations of both compounds. For DMAA, the experimental results are well explained in terms of the TICT state. In the case of PYRA in polar aprotic solvents, two alternative models are discussed: TICT state formation or inversion of the two low lying singlet states.     

Trinuclear copper(II) complex showing high selectivity for the hydrolysis of 2'-5' over 3'-5' for UpU and 3'-5' over 2'-5' for ApA ribonucleotides

The cooperative action of multiple Cu(II) nuclear centers is shown to be effective and selective in the hydrolysis of 2'-5' and 3'-5' ribonucleotides. Reported herein is the specific catalysis by two trinuclear Cu(II) complexes of L3A and L3B. Pseudo first-order kinetic studies reveal that the L3A trinuclear Cu(II) complex effects hydrolysis of Up(2'-5')U with a rate constant of 28 x 10(-)(4) min(-)(1) and Up(3'-5')U with a rate constant of 0.5 x 10(-)(4) min(-)(1). The hydrolyses of Ap(3'-5')A and Ap(2'-5')A proceed with rate constants of 24 x 10(-)(4) min(-)(1) and 0.5 x 10(-)(4) min(-)(1) respectively. The L3A trinuclear Cu(II) complex demonstrates high specificity for Up(2'-5')U and Ap(3'-5')A. Similar studies with the more rigid L3B trinuclear Cu(II) complex shows no selectivity and yields lower rate constants for hydrolysis. The selectivity observed with the L3A ligand is attributed to the geometry of the ligand-bound diribonucleotide which ultimately dictates the proximity of the attacking hydroxyl and the phosphoester to a Cu(II) center for activation and subsequent hydrolysis.     

Synthesis and mesomorphic properties of 4-methoxyphenyl 4'- n -alkoxy-2',3',5',6'-tetrafluorobiphenyl-1-carboxylates

A novel type of 4-methoxyphenyl 4'- n -alkoxy-2',3',5',6'-tetrafluorobiphenyl-1-carboxylates have been synthesized. Textural observations by polarizing microscopy and DSC measurements of the phase transitions show that all of these compounds are thermotropic liquid crystals with only a nematic mesophase. The relationship between the properties and chemical structures of these compounds is discussed.     

2,6-二[4-′(N,N-二苯基氨基)芪]苯并[1-2,4-5]二噁唑的合成与发光特性

通过对二苯氨基苯甲醛与2,6-二(4-氯甲基苯基)苯并[1-2,4-5]二唑之间的Wittig-Horner反应,设计并合成了一个2,6-二[4-′(N,N-二苯基氨基)芪]苯并[1-2,4-5]二唑新化合物,目的在于均二苯乙烯分子中同时引入空穴传输和电子传输结构单元,可望提高均二苯乙烯型发光材料的发光强度和光量子效率.采用UV-VisI、R1、HNMR和元素分析等分析方法对合成产物结构进行了确认,并考察了溶剂对其光致发光特性的影响.所合成化合物的相关分析数据表明:1)其分子中的两个均二苯乙烯基均为反式“芪”结构特征;2)随溶剂极性增高,其UV-Vis光谱和荧光光谱的λmax红移;3)可用作蓝色发光材料.     

Synthesis of [5'-13C]ribonucleosides and 2'-deoxy[5'-13C]ribonucleosides

The present efficient synthesis of [5'-13C]ribonucleosides and 2'-deoxy[5'-13C]ribonucleosides is characterized by the synthesis of the D-[5-13C]ribose derivative as an intermediate via the Wittig reaction of 4-aldehydo-D-erythrose dialkyl acetals with Ph3P13CH3I-BuLi to introduce the 13C label at the 5-position of a pentose. This was followed by the highly diastereoselective osmium dihydroxylation for the preparation of 2,3-di-O-benzyl-D-[5-13C]ribose dialkyl acetal and the cyclization from D-[5-13C]ribose dialkyl acetal derivatives to the alkyl D-[5-13C]ribofuranoside derivative by the use of LiBF(4). The obtained D-[5-13C]ribose derivative was converted into [5'-13C]ribonucleosides and subsequently into the corresponding 2'-deoxynucleosides.     

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4'-[5-(substituted methylidene)-2,3,4,5-tetrahydro-1H-1-ben zoazepine-1-carbonyl]benzanilide and 4'-[5-(substituted methyl)-2,3-dihydro-1H-1-benzoazepine-1- carbonyl]benzanilide derivatives

Arginine vasopressin (AVP) has a dual action, i.e. vasoconstriction and water reabsorption via V1A and V2 receptors, and may play a role in a number of diseases, including congestive heart failure (CHF), hypertension, renal disease, edema, and hyponatremia. We have attempted to develop a new series of AVP antagonists for both V1A and V2 receptors based on the hypothesis that the blockade of both V1A and V2 receptors might be beneficial to CHF patients. In this report, a series of compounds structurally related to 4'-[5-(substituted methylidene)-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl ]benzanilide (exo-olefin isomer) and 4'-[5-(substituted methyl)-2,3-dihydro-1H-1-benzoazepine-1-carbonyl]benzanilide (endo-olefin isomer) were synthesized and examined to have AVP antagonist activity for both V1A and V2 receptors. As a result, it was found that the (E)-exo-olefin isomers showed more potent binding affinity compared with endo-olefin isomers. Among these (E)-exo-olefin isomers, (E)-N-methyl-{1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahyd ro-1H-1 -benzoazepin-5-ylidene}acetamide (14) exhibited the most potent binding affinity and (E)-N-methyl-(1-{4-[2-(4-methylphenyl)benzoylamino]benzoyl}-2,3,4,5- tetrahydro-1H-1-benzoazepin-5-ylidene)acetamide (20) exhibited a high AVP antagonist activity for both V1A and V2 receptors after intravenous administration. Details of the synthesis and pharmacological properties of this series are presented.     

Synthesis and characterization of the oxidized dGTP lesions spiroiminodihydantoin-2'-deoxynucleoside-5'- triphosphate and guanidinohydantoin-2'-deoxynucleoside-5'- triphosphate

Two convenient synthetic routes to the oxidized guanosine triphosphate lesions spiroiminodihydantoin-2'-deoxynucleoside-5'-triphosphate (dSpTP) and guanidinohydantoin-2'-deoxynucleoside-5'-triphosphate (dGhTP) are reported. Both two-electron oxidation of 2'-deoxy-7,8-dihydro-8-oxoguanosine-5'-triphosphate (dOGTP) using SO4*- generated photolytically from K2S2O8 or four-electron oxidation of 2'-deoxyguanosine-5'-triphosphate (dGTP) from singlet oxygen provide either dSpTP or dGhTP at pH 8.0 or 4.4, respectively. Highly purified triphosphates are obtained by ion pair reversed-phase HPLC.     

2-芳基-5-[4′-(2,2,6,6-四甲基哌啶-1-氧)氨基]-1,3,4-恶二唑自旋标记化合物的合成

2,2,6,6,-四甲基哌啶-1-氧自由基是目前应用最广泛的自旋标记试剂之一,但用哌啶氮氧自由基标记1,3,4-恶二唑类杂环的研究。迄今未见报道。1,3,4-恶二唑杂环衍生物具有抗结核、